Streetbeat News

Stock Prices

GSUN

Golden Sun Education Group Ltd (GSUN) stock surged 32% to $0.78 following the announcement of a press conference on January 26, where the company will announce its strategic shift into the healthcare and wellness industry in China. The event will be attended by the company's management, local government officials, and media representatives.

Portfolio Pulse from Henry Khederian

January 24, 2024 | 4:40 pm

ANVS

Annovis Bio Inc's stock (ANVS) fell by 20.6% after the company announced a delay in releasing Phase III study data for buntanetap in Parkinson’s Disease due to data cleaning efforts. The company remains blinded to the data, with statistical analysis pending, and commits to open communication regarding the study results.

Portfolio Pulse from Henry Khederian

January 24, 2024 | 4:39 pm

BA

SPR

Spirit Aerosystems Holdings (SPR) shares are up after a report indicated Boeing may have improperly installed a fuselage panel on an Alaska MAX 9 jet, which later detached.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 4:38 pm

NFLX

TKO

Netflix Inc (NASDAQ:NFLX) reported Q4 results, beating revenue estimates but missing EPS estimates, ending the year with 260.28 million subscribers. Analysts are generally positive, with upgrades and raised price targets. The WWE deal, starting in 2025, is seen as a game-changer for audience growth and ad revenue. Analysts highlight Netflix's ad-supported plan and paid sharing as growth drivers, despite some concerns over higher content costs and free cash flow impact.

Portfolio Pulse from Chris Katje

January 24, 2024 | 4:36 pm

MSDL

Morgan Stanley Direct Lending Fund shares opened at $20.45 on their NYSE debut, lower than their IPO price of $20.67.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 4:34 pm

TXT

Textron Inc (NYSE:TXT) shares surged after Q4 results showed a mixed performance with sales missing estimates but adjusted EPS beating expectations. Textron Aviation's revenues declined, while Bell and Industrial segments reported revenue growth. The company announced a restructuring plan expected to save $75 million annually. Textron also provided a positive FY24 outlook with higher revenue and EPS projections than consensus estimates, and shared plans for continued investments in new products and programs. Shares rose 7.97% to $85.65.

Portfolio Pulse from Lekha Gupta

January 24, 2024 | 4:32 pm

RDHL

Redhill Biopharma's stock is trading higher following the grant of U.S. patent #11878011, which covers a method for eradicating Helicobacter pylori infection in patients, irrespective of their body mass index.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 4:31 pm

RDHL

Redhill Biopharma Ltd. (NASDAQ:RDHL) stock is trading higher after being granted a patent for a method to eradicate helicobacter pylori infections. The stock's volume is above average, with over 7.27 million shares traded compared to the 100-day average of 9.125 million. Additionally, Redhill announced that its investigational drugs, opaganib and RHB-107, showed a synergistic effect with remdesivir in an Ebola virus study. The company's shares have risen 22% to $1.09.

Portfolio Pulse from Erica Kollmann

January 24, 2024 | 4:30 pm

HPE

Hewlett Packard Inc. (NYSE:HPE) saw a slight increase in its stock price to $15.64, despite a decline over the past month and year. The article discusses the company's P/E ratio in comparison to the industry average, suggesting that HPE may be undervalued given its lower P/E ratio relative to the Technology Hardware, Storage & Peripherals industry. The P/E ratio is a tool for evaluating a company's market performance, but it should be used alongside other metrics and qualitative analysis for investment decisions.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 4:30 pm

EVAX

MRK

Evaxion Biotech's stock price increased following a 13G filing that revealed Merck & Co now holds an 11.4% stake in EVAX as of December 21, 2023. Additionally, EVAX announced an expanded commitment to developing tailored cancer vaccines.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 4:19 pm